drugset / Trial / NCT04295161
A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone
RandomizedCrossoverOpen-labelTreatment
Summary
A Study in Healthy Male Subjects Designed to Evaluate the Pharmacokinetic Profile of Abiraterone Following Administration of Immediate Release Formulations
Timeline
- Start
- 2019-06-25
- Primary completion
- 2019-11-08
- Completion
- 2019-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | — | — |
Indications
No indication recorded.